Daily Dose - May 14th, 2025
Daily Dose |
View online
May 14, 2025
FDA’s 2025 inspection crackdown hits 10 companies
The agency has cited several drugmakers for manufacturing lapses ranging from data integrity violations to sterility assurance failures.
Read More
WuXi Biologics divests German drug product plant in $168M deal with Terumo
The sale of WuXi’s facility in Leverkusen, Germany is meant to enable the Chinese CRDMO to focus on building large-scale global DP manufacturing capacities in Singapore.
Read More
Recipharm, ProductLife Group partner to streamline drug development and approvals
The companies aim to reduce regulatory hurdles and accelerate patient access to critical medicines.
Read More